Pacific Biosciences of California PACB Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's retained earnings?
- Pacific Biosciences of California (PACB) reported retained earnings of -$2.7B in Q1 2026.
- How has Pacific Biosciences of California's retained earnings changed year-over-year?
- Pacific Biosciences of California's retained earnings decreased by 5.0% year-over-year, from -$2.58B to -$2.7B.
- What is the long-term trend for Pacific Biosciences of California's retained earnings?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's retained earnings has grown at a 21.1% compound annual growth rate (CAGR), from -$1.04B to -$2.7B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.